Royal Bank of Canada’s GeneDx Holdings WGS Stock Holding History
Bought
Maintained
Sold
Other funds holding WGS
CM
CC
AIM
VCM
ZDA
Royal Bank of Canada's WGS Position: Q1 2026 in Review
Royal Bank of Canada reduced its GeneDx Holdings (WGS) stake by 58% in Q1 2026, selling an estimated $1.11M and leaving 8,899 shares worth $571K. The position accounts for ﹤0.01% of the portfolio, ranked #4039.
Royal Bank of Canada first reported a position in WGS in Q1 2021 and has held it in 21 quarters since. The position peaked at $2.74M in Q4 2025. 240 funds tracked by Wall St. Rank hold WGS as of Q1 2026.
- Royal Bank of Canada held 8,899 shares of GeneDx Holdings worth $571K as of Q1 2026.
- Royal Bank of Canada sold 12,137 GeneDx Holdings shares in Q1 2026, an estimated $1.11M.
- GeneDx Holdings made up ﹤0.01% of Royal Bank of Canada's portfolio in Q1 2026, its #4039 holding.
- Royal Bank of Canada first reported a position in GeneDx Holdings in Q1 2021 and has held it in 21 quarters since.
- Royal Bank of Canada's GeneDx Holdings position peaked at $2.74M in Q4 2025.
- 240 funds tracked by Wall St. Rank held GeneDx Holdings as of Q1 2026.
Based on Royal Bank of Canada's 13F filing for Q1 2026, filed 15 May 2026.